leadf
logo-loader
viewArcturus Therapeutics

Arcturus Therapeutics sees 2020 as a transformative year for company

Arcturus Therapeutics Inc (NASDAQ: ARCT) CEO Joe Payne sat down with Proactive's Steve Darling at the 12th annual LD Micro Conference in Bel Air. The San Diego-based company is developing a portfolio of RNA therapeutics for the treatment of diseases with high unmet medical needs. According to the company, RNAs play crucial roles during disease progression and represent a diverse and largely untapped class of biomolecules that can be exploited for drug development

Quick facts: Arcturus Therapeutics

Price: 40.09 USD

NASDAQ:ARCT
Market: NASDAQ
Market Cap: $977.72 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Cabral Gold adds 2nd drill rig as company identifies new high-grade veins

Cabral Gold (CVE: CBR-OTC: CBGZF) CEO Alan Carter joined Steve Darling from Proactive Vancouver with news the company has identified at least six new NE trending high-grade veins in the Machichie SW area located immediately north of the MG deposit. Carter telling Proactive what had led them...

2 days, 7 hours ago

2 min read